NANOBIOTIX (EPA:NANO) | WebDisclosure

Basculer en Français

9480	Companies
185535	Keywords
117927	Articles
99378	Press releases

Home
Companies
NANOBIOTIX

PRESS RELEASE

published on 06/12/2024 at 22:15, 1 year 5 months ago

NANOBIOTIX ORGANISE UNE DISCUSSION VIRTUELLE ENTRE EXPERTS SUR LE POTENTIEL DE NBTXR3 EN IMMUNOTHÉRAPIE DANS LE CANCER DE LA TÊTE ET DU COU ET D’AUTRES INDICATIONS LE 18 JUIN 2024
Nanobiotix organise une discussion virtuelle entre experts sur le potentiel de NBTXR3 en immunothérapie dans le cancer de la tête et du cou et d'autres indications le 18 juin 2024

Immunothérapie Cancer De La Tête Et Du Cou NANOBIOTIX NBTXR3 Discussion Virtuelle
PRESS RELEASE

published on 06/12/2024 at 22:15, 1 year 5 months ago

NANOBIOTIX to Host Virtual KOL Event Discussing Potential of NBTXR3 Combined With Immunotherapy in Head and Neck Cancer and Beyond on June 18, 2024
Nanobiotix to host virtual KOL event discussing NBTXR3 combined with immunotherapy in head and neck cancer and beyond on June 18, 2024

Immunotherapy Head And Neck Cancer NANOBIOTIX NBTXR3 Virtual KOL Event
BRIEF

published on 06/11/2024 at 22:20, 1 year 5 months ago

Nanobiotix : Informations Mensuelles sur les Droits de Vote et Actions

Droits De Vote Euronext Actions Nasdaq NANOBIOTIX
BRIEF

published on 06/11/2024 at 22:20, 1 year 5 months ago

Nanobiotix: Monthly Information on Voting Rights and Shares

Voting Rights Euronext Actions Nasdaq NANOBIOTIX
PRESS RELEASE

published on 06/11/2024 at 22:15, 1 year 5 months ago

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
Publication mensuelle du nombre total de droits de vote et d'actions de Nanobiotix le 31 mai 2024, conformément à la réglementation financière

Communication Financière Droits De Vote Capital Social Biotechnologie NANOBIOTIX
PRESS RELEASE

published on 06/11/2024 at 22:15, 1 year 5 months ago

Voting Rights and Shares Capital of the Company
Nanobiotix discloses its voting rights and shares capital information as of May 31, 2024, in compliance with regulatory requirements. The company is a clinical biotechnology firm listed on Euronext Paris and Nasdaq

Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX
BRIEF

published on 06/02/2024 at 16:05, 1 year 6 months ago

Nanobiotix Announces Promising Data on NBTXR3 for Head and Neck Cancer Patients

Clinical Trial Head And Neck Cancer NANOBIOTIX NBTXR3 ASCO
BRIEF

published on 06/02/2024 at 16:05, 1 year 6 months ago

Nanobiotix annonce des données prometteuses sur NBTXR3 pour les patients atteints d'un cancer de la tête et du cou

Essai Clinique Cancer De La Tête Et Du Cou NANOBIOTIX NBTXR3 ASCO
PRESS RELEASE

published on 06/02/2024 at 16:00, 1 year 6 months ago

Nanobiotix Announces New Data Showing Disease Control and Tumor Response in Patients Treated With RT-Activated NBTXR3 Followed By anti-PD-1 For 2l+ R/M HNSCC Naïve or Resistant to Prior anti-PD-1 Therapy
Nanobiotix announces new data from Study 1100 showing disease control and tumor response in patients with R/M HNSCC treated with RT-activated NBTXR3 followed by anti-PD-1. Investor event scheduled on June 2nd

NANOBIOTIX Study 1100 R/M HNSCC RT-activated NBTXR3 Anti-PD-1
BRIEF

published on 05/28/2024 at 22:20, 1 year 6 months ago

NANOBIOTIX Présente de Nouvelles Données à l'ASCO 2024

Immunothérapie NANOBIOTIX NBTXR3 ASCO Phase 1

Accesswire

Published on 12/05/2025 at 19:50, 3 minutes ago

Gold, Rare Earth Minerals, Digital Assets: The Market Just Realized SMX Sits in All Three
Published on 12/05/2025 at 19:20, 33 minutes ago

The Multi-Sector Validation Shock: Why SMX Became Impossible for Markets to Ignore
Published on 12/05/2025 at 18:45, 1 hour 8 minutes ago

Four Global Markets, One Engine: SMX Just Redefined What a Supply Chain Can Prove
Published on 12/05/2025 at 18:20, 1 hour 33 minutes ago

NuRAN Announces Intention to Complete Consolidation in Preparation to the Restructuring Transaction
Published on 12/05/2025 at 18:00, 1 hour 53 minutes ago

SMX: A New Supply Chain Reality in the World's Four Largest Markets

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 18:58, 55 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 1 hour 27 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 1 hour 38 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:51, 2 hours 2 minutes ago

Issue of Equity
Published on 12/05/2025 at 17:46, 2 hours 7 minutes ago

Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds

Les Echos

Published on 12/05/2025 at 17:18, 2 hours 35 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 2 hours 35 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 4 hours 43 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 4 hours 43 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 5 hours 55 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE